Search results
-
Bristol overtakes Amgen in colorectal
… 2022 based on Krystal-1; confirmatory Krystal-12 data at ASCO 2024 Ph3 Krystal-7, data due 2028 AA 2L Jun 2024 …
- 06/25/2024 - 13:42 -
ASCO 2024 movers – Affimed wins, Caribou loses
ASCO 2024 movers – Affimed wins, Caribou loses … tumbling 26%. Several other stocks moved yesterday too, but ASCO 2024’s most significant biotech beneficiary is …
- 06/10/2024 - 16:07 -
ASCO 2024 – Yervoy makes the difference in front-line liver cancer
ASCO 2024 – Yervoy makes the difference in front-line …
- 06/21/2024 - 15:49 -
ASCO 2024 – AstraZeneca’s GPC3 secret sauce
ASCO 2024 – AstraZeneca’s GPC3 secret sauce …
- 06/06/2024 - 19:22 -
ASCO 2024 – J&J shifts to a new radiopharma dosing strategy
ASCO 2024 – J&J shifts to a new radiopharma dosing …
- 06/04/2024 - 17:26 -
ASCO 2024 – IDRx shoots for an early-line gist
ASCO 2024 – IDRx shoots for an early-line gist … with IDRX-42 in GIST Venue CTOS Nov 2023 ASCO 2024 abstract May 2024 ASCO 2024 presentation Jun 2024 Cutoff date 5 …
- 01/13/2025 - 09:40 -
ASCO 2024 – two more Echelon-3 surprises
ASCO 2024 – two more Echelon-3 surprises …
- 06/03/2024 - 00:48 -
ASCO 2024 – Pfizer’s KAT6 inhibitor purrs
ASCO 2024 – Pfizer’s KAT6 inhibitor purrs …
- 06/03/2024 - 00:47 -
ASCO 2024 – USP1 lives on, for now
ASCO 2024 – USP1 lives on, for now …
- 06/03/2024 - 00:48 -
ASCO 2024 – acasunlimab impresses on overall survival
ASCO 2024 – acasunlimab impresses on overall survival … date 22 Mar 2024 for ORR & 1 May 2024 for OS. Source: ASCO 2024 poster. Conferences …
- 06/03/2024 - 00:48
